An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)

CompletedOBSERVATIONAL
Enrollment

1,376

Participants

Timeline

Start Date

October 15, 2009

Primary Completion Date

April 28, 2016

Study Completion Date

July 1, 2016

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

CPT-11 based regimens

Trial Locations (1)

359-8513

Department of Clinical Oncology, National Defense Medical College Hospital, Tokorozawa-shi

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY